Detalhe da pesquisa
1.
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture.
Cytotherapy
; 25(3): 323-329, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513573
2.
The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes.
Transfusion
; 60(10): 2192-2198, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32905635
3.
Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature.
Lancet Infect Dis
; 24(4): e256-e265, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310904
4.
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma.
Hemasphere
; 8(1): e29, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38434533
5.
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.
Leuk Lymphoma
; 64(12): 2037-2041, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602678
6.
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.
Leuk Lymphoma
; 63(8): 1980-1984, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481791